![Christopher Peetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Peetz
Oprichter bij
MIRUM PHARMACEUTICALS, INC.
Vermogen: 39 M $ op 30-09-2026
Profiel
Christopher Peetz is the founder of Mirum Pharmaceuticals, Inc., founded in 2018, serving as Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Satiogen Pharmaceuticals, Inc. and Independent Director at Arcutis Biotherapeutics, Inc. starting in 2026.
Former jobs include Chief Executive Officer at Flashlight Therapeutics, Inc. from 2017 to 2019; Senior Director-Corporate Development & Strategy at Onyx Pharmaceuticals, Inc. from 2007 to 2012; Independent Director at Alpine Immune Sciences, Inc. from 2018 to 2024; Principal at TerraVia Holdings, Inc.; Vice President-Finance & Development at SillaJen Biotherapeutics, Inc. from 2012 to 2014; and Chief Financial Officer & Head-Development at Tobira Therapeutics, Inc. from 2014 to 2016.
Education includes undergraduate studies at Washington University in St. Louis and an MBA from Stanford Graduate School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-10-2026 | 394.137 ( 0,61% ) | 34 M $ | 30-09-2026 | |
| 15-07-2026 | 191.815 ( 0,15% ) | 5 M $ | 30-09-2026 |
Actieve functies van Christopher Peetz
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Oprichter | 07-05-2018 |
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 15-07-2026 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Algemeen Directeur | - |
Eerdere bekende functies van Christopher Peetz
| Bedrijven | Functie | Einde |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur/Bestuurslid | 20-05-2024 |
Flashlight Therapeutics, Inc.
 Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Algemeen Directeur | 01-05-2019 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Financieel Directeur/CFO | 01-12-2016 |
| TOBIRA THERAPEUTICS INC | Financieel Directeur/CFO | 01-12-2016 |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Corporate Officer/Principal | 01-03-2014 |
Opleiding van Christopher Peetz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
TerraVia Holdings, Inc.
 TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells food, nutrition and specialty ingredients from algae | Consumer Non-Durables |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Flashlight Therapeutics, Inc.
Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
